To identify common genetic variants that contribute to lung cancer susceptibility, we conducted a multistage genome-wide association study of lung cancer in Asian women who never smoked. We scanned 5,510 never-smoking female lung cancer cases and 4,544 controls drawn from 14 studies from mainland China, South Korea, Japan, Singapore, Taiwan and Hong Kong. We genotyped the most promising variants (associated at P < 5 × 10 −6 ) in an additional 1,099 cases and 2,913 controls. We identified three new susceptibility loci at 10q25.2 (rs7086803, P = 3.54 × 10 −18 ), 6q22.2 (rs9387478, P = 4.14 × 10 −10 ) and 6p21.32 (rs2395185, P = 9.51 × 10 −9 ). We also confirmed associations reported for loci at 5p15.33 and 3q28 and a recently reported finding at 17q24.3. We observed no evidence of association for lung cancer at 15q25 in neversmoking women in Asia, providing strong evidence that this locus is not associated with lung cancer independent of smoking.
To identify common genetic variants that contribute to lung cancer susceptibility, we conducted a multistage genome-wide association study of lung cancer in Asian women who never smoked. We scanned 5,510 never-smoking female lung cancer cases and 4,544 controls drawn from 14 studies from mainland China, South Korea, Japan, Singapore, Taiwan and Hong Kong. We genotyped the most promising variants (associated at P < 5 × 10 −6 ) in an additional 1,099 cases and 2,913 controls. We identified three new susceptibility loci at 10q25.2 (rs7086803, P = 3.54 × 10 −18 ), 6q22.2 (rs9387478, P = 4.14 × 10 −10 ) and 6p21.32 (rs2395185, P = 9.51 × 10 −9 ). We also confirmed associations reported for loci at 5p15.33 and 3q28 and a recently reported finding at 17q24.3. We observed no evidence of association for lung cancer at 15q25 in neversmoking women in Asia, providing strong evidence that this locus is not associated with lung cancer independent of smoking.
It is estimated that 25% of lung cancer cases arise in individuals who never smoked. Lung cancer in never smokers ranks as the seventh most common cause of cancer death worldwide 1 . A number of observations suggest that the molecular pathogenesis of lung cancer differs by smoking status. Differences have been reported by smoking status in cellular and molecular carcinogenic pathways, distinct profiles of oncogenic mutations (for example, in EGFR) and response to targeted therapy 2, 3 . Compared to lung cancer in smokers, cases in never smokers are more likely to arise in women at a younger age, and there is a greater proportion of cases with the adenocarcinoma histology subtype 3 . Epidemiological studies of lung cancer in never smokers have shown that the incidence of lung cancer in women is particularly high in Asia 4 , which is partially attributed to exposure to environmental tobacco smoke, combustion products from indoor heating and cooking fuel, and cooking oil fumes 4-10 . Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia
To gain insight into the etiology of lung cancer in never-smoking women, we formed the Female Lung Cancer Consortium in Asia (FLCCA), which includes studies drawn from mainland China, South Korea, Japan, Singapore, Taiwan and Hong Kong. Previously, we published the first genome-wide association study (GWAS) of lung cancer in neversmoking Asian women, including 584 cases and 585 controls with large-scale replication, reporting an association at 5p15.33 near the TERT gene 11 ; in this study, it was also notable that the estimated effect of the associated locus was greater in nonsmoking Asian women than the reported effect size observed in primarily smokers of European ancestry 12 . We also confirmed an association signal in TP63 at 3q28 (ref. 13) , replicating the report from a GWAS conducted in Japan 14 .
To identify new susceptibility loci in Asian never-smoking women, we conducted a lung cancer GWAS in 14 studies (13 case-control studies and 1 cohort study; Supplementary Table 1 and Supplementary Note). Samples were scanned at six centers (Online Methods): the US National Cancer Institute (NCI) Cancer Genomic Research (CGR) Laboratory, the Genome Institute of Singapore, the Memorial Sloan-Kettering Cancer Center (MSKCC), GeneTech Biotech in Taiwan, Gene-Square Biotech in Beijing and deCODE Genetics in Iceland. After stringent quality control analysis of genotypes (Online Methods), we combined data sets for 5,510 lung cancer cases and 4,544 controls using a previously described clustering algorithm 15 . The primary analysis was performed using logistic regression for genotype trend effect (with 1 degree of freedom) adjusted for study center, age and three eigenvectors (on the basis of principal-components analysis). A comparison of the observed and expected P values in the quantile-quantile plot showed an enrichment of observed signals with small P values compared to the null distribution of no association, with little evidence for genomic inflation (unscaled λ = 1.014, λ 1000 = 1.003; Supplementary Fig. 1 ) 16 .
The overall association results are shown in a Manhattan plot, in which we observed both new and known loci that exceeded the threshold for genome-wide significance (P < 5 × 10 −8 ; Fig. 1 ). We observed association at two previously established loci, rs2736100 at 5p15. 33 (refs. 11,12,14,17-19) and rs4488809 at 3q28 (refs. 13,14) . We also observed support for association of a recently reported locus marked by rs7216064 at 17q24. 3 (ref. 20) (Supplementary Table 2) . Notably, there was no evidence for association across the 15q25 region, which has been associated with smoking-related lung cancer 12, 19, [21] [22] [23] [24] . We did not observe strong association signals for other loci reported in either European 25 or Asian 17,26 populations (Supplementary Table 2 ).
In our primary scan, we observed one new locus at 10q25.2, marked by rs7086803, that substantially exceeded the threshold for genome-wide significance (odds ratio (OR) = 1.32, 95% confidence interval (CI) = 1.24-1.41; P = 5.04 × 10 −17 ) ( Fig. 1 and Table 1 ). We developed assays to genotype 13 SNPs associated at P < 5 × 10 −6 in the initial scan, using analysis of all cases or the most common subtype in nonsmokers, adenocarcinoma. We genotyped 1,099 new cases and 2,913 controls drawn from the same studies as in the initial scan. In a combined analysis of 6,609 cases and 7,457 controls, 3 new loci achieved associations at genome-wide significance ( Analysis by histological subtype of lung cancer showed that both the 6q22.2 (rs9387478) and 6p21.32 (rs2395185) loci were associated with adenocarcinoma only, which comprised 71% of cases ( Table 2 ). The estimated effects were consistent across studies (Supplementary Fig. 2 ). We note that rs7086803 showed a somewhat larger effect for squamous carcinoma compared to adenocarcinoma ( Table 2) , but, as the number of squamous carcinoma cases analyzed was small, we consider this a preliminary observation requiring independent replication.
To explore the relationship between these three regions and lung cancer in populations of European ancestry, we analyzed data from a previously reported GWAS of 5,718 lung cancer cases and 5,739 controls, including men and women who were primarily ever smokers 12 . We found no evidence for association at the three newly associated loci. In a subanalysis of 350 never-smoker cases and 1,379 never-smoker controls drawn from this study, we observed some evidence of association for rs2395185 (M.T.L., unpublished data), but larger studies are warranted.
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At the 6q22 locus, six SNPs were highly correlated with rs9387478 (r 2 = 0.99-1.00). Two SNPs, rs9387478 and rs6937083 (pairwise r 2 = 1), were observed within a region defined by the Encyclopedia of DNA Elements (ENCODE) as containing both chromatin state segmentation and enhancer-and promoter-associated histone marks. Although the evidence for evolutionary conservation is weak (that is, a crossspecies sequence alignment comparison indicated conservation at the site of ~29.2 million years since divergence from a common ancestor), rs6937083 falls within an ENCODE-predicted transcription factorbinding site and an exon of the AceView-predicted gene, DCBLD1. The architecture of the region on chromosome 10q25 is more complicated because there are 23 perfectly correlated SNPs (r 2 = 1) and 1 highly correlated SNP (r 2 = 0.99). All localize to intron 7 or the UTR of one transcript of the VTI1A gene (encoding vesicle transport through interaction with t-SNAREs homolog 1A (yeast)). Sixteen fall within putatively functional regions, defined as ENCODE DNase I hypersensitivity clusters, chromatin state segmentation, the UTR of VTI1A, ENCODE enhancer-and promoter-associated histone marks and/or highly conserved (that is, a cross-species sequence alignment comparison indicated conservation at the site of 300 million years since divergence from a common ancestor) regions (Supplementary Table 5 ). rs11196080 is noteworthy because many of the functionally predicted areas converge on this SNP, making this a high-priority variant for functional follow-up studies.
The strongest new association signal, rs7086803 at 10q25.2, maps to intron 7 of the VTI1A gene, which has been implicated in lung carcinogenesis. Loss of VTI1A activity has been reported to reduce high-frequency spontaneous neurotransmitter release 29 and rapid progressive neurodegeneration in the peripheral ganglia 30 . VTI1A is also involved in Acrp30-containing vesicles in adipocytes, and lower amounts of VTI1A in cultured adipocytes can inhibit adiponectin secretion 31 . Lower amounts of adiponectin have previously been associated with advanced lung cancer 31, 32 . A recent study reported recurrent VTI1A-TCF7L2 fusions in colorectal cancers, and a colorectal carcinoma cell line with the fusion gene was shown to be dependent on VTI1A-TCF7L2 for anchorage-independent growth 33 .
The rs9387478 SNP at 6q22.2 is located in an interval that contains two candidate genes: DCBLD1 (encoding discoidin, CUB and LCCL domain containing 1) and ROS1 (encoding the ROS proto-oncogene receptor tyrosine kinase). ROS1 functions as both an integral membrane protein and a receptor tyrosine kinase 34 . Expression of Ros1 is specifically increased in lung cancer tissue in mouse models, and ROS1 expression levels are higher in non-small cell lung cancer (NSCLC) 35 . ROS1 fusions in lung adenocarcinoma and NSCLC, particularly in Asian never smokers, have been identified as drivers of oncogenesis [36] [37] [38] . ROS1 rearrangements were found to be more common in lung adenocarcinomas from never smokers and younger affected individuals 39 . There is limited evidence concerning the functional role of the protein encoded by DCBLD1; a related gene at 3q12.2, DCBLD2 (encoding discoidin, CUB and LCCL domain containing 2; also known as CLCP1) regulates cellular proliferation and invasion and may have an important role in cancer metastasis [40] [41] [42] .
The third locus, marked by rs2395185 at 6p21.3, is located within 20 kb of HLA-DRA (encoding major histocompatibility complex, class II, DRα) and 52 kb downstream of HLA-DRB5 (encoding major histocompatibility complex, class II, DRβ5). There was no evidence for strong linkage disequilibrium (LD) between this SNP and other SNPs at 6p21.32 reported to be associated with lung cancer 17, 23 . There was little LD with a recently reported SNP at 6p21.3, rs3817963, which was associated with lung cancer in a Japanese population 20 ; the r 2 in Han Chinese and Japanese HapMap samples was 0.18 and 0.10, respectively, and D was 0.57 and 0.43, respectively. These data suggest that our locus probably represents a new HLA class II-related finding for nonsmoking lung cancer susceptibility. Further mapping across the complex HLA region is required to characterize the specific susceptibility alleles or haplotypes involved in nonsmoking lung cancer risk. We also note that rs2395185 has been previously associated with ulcerative colitis 43 , Hodgkin lymphoma 44 and type 1 diabetes 45 .
In previous GWAS of lung cancer, in which a majority of cases were smokers, SNPs across a region at 15q25 have been associated with lung cancer risk 12, 19, [21] [22] [23] [24] . However, studies of smoking-related behavior have also identified variants at 15q25, raising the possibility that the variants previously identified by GWAS for lung cancer could mediate risk through effects on tobacco use 46 . We previously genotyped additional SNPs across 15q25 in Asian studies and observed no evidence of association with lung cancer in never-smoking Asian females 11 . Notably, in our current, larger study, there was no evidence for association with lung cancer at 15q25 in the never-smoking population overall or in the major subtypes. These data provide strong evidence that this locus is not associated with lung cancer independent of smoking in never-smoking females in Asia, which contrasts with the results from a smaller Asian study 24 but is consistent with previous reports from smaller studies conducted in populations of European ancestry 12, 47, 48 .
We investigated the relationship between our new loci and known environmental exposures. The association between exposure to npg l e t t e r s environmental tobacco smoke in the home and adenocarcinoma in the five studies with data available yielded an OR of 1.36 (P = 1.2 × 10 −4 ) in an analysis of 1,770 cases and 2,675 controls, consistent with previous reports 8 . The effect of environmental tobacco smoke was stronger for subjects with the GG genotype at rs2395185, with OR = 1.78 (P = 1.15 × 10 −5 ), compared to subjects with the GT or TT genotypes, OR = 1.16 (P = 0.15), with P interaction = 0.002. The association between the T allele at rs2395185 and risk of adenocarcinoma in subjects with and without exposure to environmental tobacco smoke yielded OR = 1.13 (P = 0.031) and OR = 1.43 (P = 5.6 × 10 −4 ), respectively, with P interaction = 0.037. There was no evidence of interaction with the other two new loci reported here. In summary, we conducted a GWAS of lung cancer in neversmoking females in Asia and identified three new susceptibility loci at 10q25.2, 6q22.2 and 6p21.32. We also confirmed associations with two previously reported regions at 5p15.3 and 3q28 and a recently reported locus at 17q24.3. It is notable that our strongest finding at 10q25.2 has not been reported previously in lung cancer GWAS. This observation suggests that the etiology of lung cancer in never smokers in Asia may have unique genetic characteristics. This is consistent with the distinct pattern of environmental risk factors that have been causally linked to lung cancer in never-smoking females in Asia [4] [5] [6] [7] [8] 10 and the distinct molecular phenotypes of lung cancer in never smokers 2, 3 . Further work is warranted to map the new regions. Functional work is required to identify the variants that directly account for the underlying association, as well as to study how the genetic variants interact with established environmental risk factors, including environmental tobacco smoke, cooking fumes and fuel use, in never-smoking females in Asia. 
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Accession codes. The CGEMS data portal provides access to individual-level data for investigators from certified scientific institutions after approval of their submitted Data Access Request. C., N. Chatterjee, C.A.H., H.D.H., W.H., M.Y., I.-S.C., C.-F.H., W.-C.W Table 1 ). Cases had histologically confirmed lung cancer. Each participating study obtained informed consent from study participants and approval from its respective institutional review board for this study. Studies obtained institutional certification permitting data sharing in accordance with the US National Institutes of Health (NIH) Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies (GWAS), with the exception of the component of the GELAC study that was not scanned at the NCI.
Genotyping and quality control. Genome-wide scanning data came from two sources. Internal sets (HKS, SNU, CNULCS, SWHS, YLCS and components of samples from Japan and GELAC) were genotyped at the NCI CGR Laboratory using the Illumina 660W SNP microarray. External sets were genotyped as follows: (i) samples from CAMSCH, FLCS, GDS, SLCS, TLCS and WLCS were genotyped on contract at Gene-Square Biotech in Beijing using the Illumina 660W SNP microarray; (ii) samples from GELAC were genotyped on contract at GeneTech Biotech in Taiwan on the Illumina 370K SNP microarray in a pilot project, and remaining samples were genotyped on contract at deCODE Genetics in Iceland using the Illumina 610Q SNP microarray and initially reported elsewhere 11 ; (iii) a subset of samples from Japan were genotyped at MSKCC using the Illumina 610Q SNP microarray; and (iv) samples from Singapore were genotyped at the Genome Institute of Singapore on the Illumina 660W SNP microarray. The scanned intensity data from external sources were collected, and genotypes were clustered and called at the CGR using Illumina Genome Studio v2011.1 on the basis of the GenTrain2 calling algorithm. Genotype clusters were estimated from samples with preliminary completion rates of greater than 98% per cluster group.
Genotyping was attempted for a total of 5,568 samples on the Illumina 660W SNP microarray at the CGR. Six samples could not be loaded into Illumina Genome Studio because of their low intensities, and 16 samples failed to scan because of broken chips. In addition, a total of 5,946 samples were genotyped at Gene-Square Biotech (3,828), deCODE Genetics and GeneTech Biotech (1,232), MSKCC (374) and the Genome Institute of Singapore (512); the distribution of samples genotyped per SNP microarray chip was as follows: Illumina 660W (4,340), Illumina 610Q (1,494) and Illumina 370K (112). Seven samples (all from Gene-Square Biotech) could not be loaded into Illumina Genome Studio because of their low intensities. In addition, 111 samples from 4 studies (FLCS, GDS, SLCS and TLCS) were excluded due to laboratory processing errors. The combined 11,374 samples with genotypes mapped to 11,025 unique individuals drawn from 14 studies.
We subsequently performed quality control filtering at the sample level in 19 quality control groups (Supplementary Table 6 ). Samples were exclude that had low completion rates (n = 725 samples) and extreme mean heterozygosity rates (n = 116). Thresholds were chosen on the basis of the sample completion rate or sample mean heterozygosity distribution for each quality control group (Supplementary Table 6 ) and on the basis of discordant expected duplicate samples (n = 6). There were samples that were excluded for multiple reasons, and the total number of unique samples excluded was 761 (Supplementary  Table 6b ). Genotype data for the remaining 10,613 samples were merged, resulting in data from 10,312 unique individuals. The genotype concordance rate for expected duplicates (n = 311) was greater than 99.9%. Further quality control analysis at the individual level led to the exclusion of samples with (i) gender discordance (n = 94); (ii) less than 86% Asian ancestry (n = 3); (iii) first-degree relatives who were also genotyped in the study (n = 136 subjects); and (iv) incomplete phenotype or unknown histology, as well as those who had ever smoked or were deemed ineligible (n = 15). Thus, the total number of scanned subjects after both quality control and analytic exclusions was 10,054 (5,510 cases and 4,544 controls). A summary of the number of excluded loci by study is shown in Supplementary Table 6c .
TaqMan custom genotyping assays (Applied Biosystems) were designed and optimized for 13 SNPs, including 9 in the NCI scan data and 4 surrogates not in this scan. In an analysis of 385 samples from 7 studies, comparison of the Illumina calls with the results from TaqMan assays conducted at the NCI CGR showed an average concordance rate of 99.97% (with a range of 99.7-100%) for the overlapping 9 SNPs. The Cancer Institute and Hospital at the Chinese Academy of Medical Sciences also conducted TaqMan genotyping for 7 SNPs on 201 previously scanned samples from 5 studies. Comparison of the Illumina calls with the results of TaqMan assays showed an average concordance rate of 99.93% (with a range of 99.5-100%). In examining the concordance between rs2395185 (scan) and its perfect surrogate rs28366298 (TaqMan), we applied genotype mapping GG→AA, GT→AC and TT→CC to confirm reproducibility of genotyping between platforms.
For the replication phase, we analyzed an additional 3,933 individuals (1,023 cases and 2,910 controls) with TaqMan data, and an additional 79 individuals (76 cases and 3 controls) genotyped using the Illumina 660W array at Gene-Square Biotech were available for analysis. Thus, the final number of subjects included in the analyses was 14,066 (6,609 cases and 7,457 controls; Supplementary Table 1) . SNP assays with locus call rates lower than 90% or Hardy-Weinberg equilibrium P values less than 1.0 × 10 −7 in each quality control group were excluded. In total, 596,032 SNPs remained in the analytic data set. After setting the minimum minor allele frequency (MAF) to 0.01, we excluded 83,806 loci from the association analysis. Thus, 512,226 SNPs were analyzed in the association studies reported here.
Statistical analyses. Data analysis and management were performed with GLU (Genotyping Library and Utilities version 1.0), a suite of tools available as an open-source application for the management, storage and analysis of GWAS data. Assessment of the population structure of study participants was performed with the GLU struct.admix module using the Japanese in Tokyo, Japan (JPT) and Han Chinese in Beijing, China (CHB), Utah residents of Northern and Western European ancestry (CEU) and Yoruba from Ibadan, Nigeria (YRI) samples as the reference populations (HapMap Build 28). A set of 33,165 SNPs with low pairwise correlation (r 2 < 0.01) was selected for this analysis. Three individuals were estimated to have less than 86% Asian ancestry ( Supplementary Fig. 4) .
The genotypes for all subject pairs were computed for cryptic relatedness using the GLU qc.ibds module with the same set of selected SNPs. In addition to 68 pairs of unexpected duplicates, we detected 33 parent-offspring and 41 full-sibling pairs. For the 142 unexpected duplicates and first-degree relative pairs, 1 subject from each simple pair was excluded. For each family with multiple relative pairs detected, only one randomly chosen subject was included in the principal-components analysis (PCA). To address the underlying population substructure, PCA was conducted using the GLU struct.pca module, a program similar to EIGENSTRAT 49, 50 , with the same set of SNPs (Supplementary Fig. 5a,b) . Three samples with less than 86% Asian ancestry were excluded on the basis of PCA.
Association analysis. Association analyses were conducted using logistic regression, adjusted for age (in 10-year categories), study group and eigenvectors, if they were significant when analyzed in the base models. For analysis of all cases versus controls, we adjusted for EV1, EV2 and EV4. For analysis of adenocarcinoma cases versus controls, we adjusted for EV2 and EV4. For analysis of squamous cell cases versus controls, we adjusted for EV8. Each SNP genotype was coded as a count of minor alleles (trend effect). A score test with 1 degree of freedom was performed on all genetic parameters in each model to determine statistical significance. The unscaled λ value for all cases versus controls in the main effect model was 1.014, and λ 1000 was 1.003, with corrected λ calculated as λ corrected = 1 + (λ -1) × (n case −1 + n control −1 )/(2 × 10 0−3 ). We assessed heterogeneity in genetic effects across studies using the Cochran's Q statistic, which conforms to a χ-squared distribution with k -1 degree of freedom, where k is the number of studies.
For the inclusion of TaqMan data for the SNPs that failed assay design (rs2395185 and rs10197940), we conducted a fixed-effects meta-analysis by combining the aggregate results from their perfect surrogates (rs28366298 and rs2290368, respectively) scanned in the GWAS with their own results based only on the additional TaqMan samples not used in the GWAS association analyses.
Genotype-environment interactions with environmental tobacco smoke were assessed using logistic regression for studies with such information available and adjusted by age, study group, the main effect of the SNP and environmental tobacco smoke, and the interaction term. 
